DICE Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
DICE Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2020 to Q3 2022.
  • DICE Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $83K, a 38.3% increase year-over-year.
  • DICE Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2022 was $268K.
  • DICE Therapeutics, Inc. annual Interest Expense for 2021 was $174K, a 1238% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $268K $83K +$23K +38.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $245K $65K +$13K +25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $232K $60K +$58K +2900% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $174K $60K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $60K +$57K +1900% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $52K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $3K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.